Amitriptyline inhibits serotonin receptor, norepinephrine receptor, 5-HT4, 5-HT2 and sigma 1 receptor with IC50 of 3.45 nM, 13.3 nM, 7.31 nM, 235 nM and 287 nM, respectively.
Amitriptyline inhibits serotonin receptor, norepinephrine receptor, 5-HT4, 5-HT2 and sigma 1 receptor with IC50 of 3.45 nM, 13.3 nM, 7.31 nM, 235 nM and 287 nM, respectively.
Amitriptyline inhibits serotonin receptor, norepinephrine receptor, 5-HT4, 5-HT2 and sigma 1 receptor with IC50 of 3.45 nM, 13.3 nM, 7.31 nM, 235 nM and 287 nM, respectively.
Amivantamab (JNJ-61186372) is a human EGFR-MET bispecific antibody with immune anticancer activity. Amivantamab inhibits ligand binding, promotes endocytosis and degradation of receptor-antibody complexes, and induces Fc-dependent cytokinesis in macrophages and antibody-dependent cytotoxicity in natural killer cells.
Amlexanox is a specific inhibitor of IKKε and TBK1, with an IC50 of approximately 1-2 μM.
Amlexanox is a specific inhibitor of IKKε and TBK1, with an IC50 of approximately 1-2 μM.
Amlexanox is a specific inhibitor of IKKε and TBK1, with an IC50 of approximately 1-2 μM.
Amlodipine is a long-acting calcium channel blocker, used to lower blood pressure and prevent chest pain.
Amlodipine is a long-acting calcium channel blocker, used to lower blood pressure and prevent chest pain.
Amlodipine is a long-acting calcium channel blocker, used to lower blood pressure and prevent chest pain.
Amlodipine Besylate is a long-acting calcium channel blocker, used to lower blood pressure and prevent chest pain.
Amlodipine maleate is a dihydropyridine calcium channel blocker, acts as an orally active antianginal agent.